Publication:
Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro

dc.contributor.authorDimas, K.
dc.contributor.authorYerlikaya, Azmi
dc.contributor.buuauthorUlukaya, Engin
dc.contributor.buuauthorSarımahmut, Mehmet
dc.contributor.buuauthorCevatemre, Buse
dc.contributor.buuauthorArı, Ferda
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFen Edebiyat Fakültesi
dc.contributor.departmentTıbbi Biyokimya Ana Bilim Dalı
dc.contributor.departmentBiyoloji Bölümü
dc.contributor.orcid0000-0003-2647-5875
dc.contributor.orcid0000-0002-6729-7908
dc.contributor.orcid0000-0003-4875-5472
dc.contributor.researcheridK-5792-2018
dc.contributor.researcheridAAG-8288-2021
dc.contributor.researcheridAAG-7012-2021
dc.contributor.researcheridAHD-2050-2022
dc.contributor.scopusid6602927353
dc.contributor.scopusid44661687400
dc.contributor.scopusid55693788600
dc.contributor.scopusid24376085300
dc.date.accessioned2024-03-05T07:58:58Z
dc.date.available2024-03-05T07:58:58Z
dc.date.issued2014-03-13
dc.identifier.citationUlukaya, E. vd. (2014). "Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro". Biomedicine and Pharmacotherapy, 68(4), 477-482.
dc.identifier.doihttps://doi.org/10.1016/j.biopha.2014.03.013
dc.identifier.eissn1950-6007
dc.identifier.endpage482
dc.identifier.issn0753-3322
dc.identifier.issue4
dc.identifier.pubmed24755119
dc.identifier.scopus2-s2.0-84901590452
dc.identifier.startpage477
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0753332214000419
dc.identifier.urihttps://hdl.handle.net/11452/40199
dc.identifier.volume68
dc.identifier.wos000336538400012
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.bapUAP(T)-2010/37
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.journalBiomedicine and Pharmacotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBreast cancer
dc.subjectCytotoxicity
dc.subjectChemotherapy
dc.subjectFenretinide
dc.subjectTRAIL
dc.subjectGrowth-inhibition
dc.subjectDeath receptors
dc.subjectCisplatin
dc.subjectInduction
dc.subjectIdentification
dc.subjectCombination
dc.subjectP53
dc.subjectTarget
dc.subjectMechanism
dc.subjectTrial
dc.subjectResearch & experimental medicine
dc.subjectPharmacology & pharmacy
dc.subject.emtreeAdenosine triphosphate
dc.subject.emtreeCaspase 3
dc.subject.emtreeFenretinide
dc.subject.emtreeNicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
dc.subject.emtreeTumor necrosis factor related apoptosis inducing ligand
dc.subject.emtreeAntineoplastic agent
dc.subject.emtreeDrug effects
dc.subject.emtreeFenretinide
dc.subject.emtreeApoptosis
dc.subject.emtreeArticle
dc.subject.emtreeBreast cancer
dc.subject.emtreeBreast metastasis
dc.subject.emtreeCancer cell culture
dc.subject.emtreeCell death
dc.subject.emtreeCell structure
dc.subject.emtreeCell viability assay
dc.subject.emtreeCytotoxicity
dc.subject.emtreeEnzyme linked immunosorbent assay
dc.subject.emtreeFluorescence imaging
dc.subject.emtreeFluorescence microscopy
dc.subject.emtreeIn vitro study
dc.subject.emtreePolyacrylamide gel electrophoresis
dc.subject.emtreePriority journal
dc.subject.emtreeWestern blotting
dc.subject.emtreeApoptosis
dc.subject.emtreeBreast neoplasms
dc.subject.emtreeDrug potentiation
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeMetabolism
dc.subject.emtreeMetastasis
dc.subject.emtreePathology
dc.subject.emtreeTumor cell line
dc.subject.meshAntineoplastic combined chemotherapy protocols
dc.subject.meshApoptosis
dc.subject.meshBlotting, western
dc.subject.meshBreast neoplasms
dc.subject.meshCaspase 3
dc.subject.meshCell line, tumor
dc.subject.meshDrug synergism
dc.subject.meshEnzyme-linked immunosorbent assay
dc.subject.meshFemale
dc.subject.meshFenretinide
dc.subject.meshHumans
dc.subject.meshMicroscopy, fluorescence
dc.subject.meshNeoplasm metastasis
dc.subject.meshPoly(adp-ribose) polymerases
dc.subject.meshTnf-related apoptosis-inducing ligand
dc.subject.scopusFenretinide; Apoptosis; Neuroblastoma
dc.subject.wosMedicine, research & experimental
dc.subject.wosPharmacology & pharmacy
dc.titleAdditive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Tıbbi Biyokimya Ana Bilim Dalı
local.contributor.departmentFen Edebiyat Fakültesi/Biyoloji Bölümü
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: